Piotr Wiland

4.9k total citations
152 papers, 2.6k citations indexed

About

Piotr Wiland is a scholar working on Rheumatology, Immunology and Hematology. According to data from OpenAlex, Piotr Wiland has authored 152 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 80 papers in Rheumatology, 55 papers in Immunology and 23 papers in Hematology. Recurrent topics in Piotr Wiland's work include Rheumatoid Arthritis Research and Therapies (47 papers), Systemic Lupus Erythematosus Research (30 papers) and Autoimmune and Inflammatory Disorders Research (20 papers). Piotr Wiland is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (47 papers), Systemic Lupus Erythematosus Research (30 papers) and Autoimmune and Inflammatory Disorders Research (20 papers). Piotr Wiland collaborates with scholars based in Poland, United States and South Korea. Piotr Wiland's co-authors include Jerzy Świerkot, Jacek Szechiński, Yuh‐Yuan Shiau, Klaus Boening, Mieszko Więckiewicz, Anna Paradowska-Stolarz, Lucyna Korman, Katarzyna Bogunia‐Kubik, Beata Nowak and Agata Sebastian and has published in prestigious journals such as SHILAP Revista de lepidopterología, International Journal of Molecular Sciences and Annals of the Rheumatic Diseases.

In The Last Decade

Piotr Wiland

139 papers receiving 2.5k citations

Peers

Piotr Wiland

RHEUM

IMMUN

ONCOL

PFM

Sławomir Jeka Poland

Paweł Hrycaj Poland

Won Park South Korea

Marek Brzosko Poland

Dorothy McCabe United States

B Freundlich United States

Reinhard Klingel Germany

Keith A. Betts United States

Daniel Burge United States

C. Gaujoux-Viala France

Sławomir Jeka Poland

Piotr Wiland

1.1k ×1.1

RHEUM

1.1k ×1.0

IMMUN

159 ×0.5

176 ×0.6

ONCOL

175 ×0.6

PFM

Citations per year, relative to Piotr Wiland Piotr Wiland (= 1×) peers Sławomir Jeka

Countries citing papers authored by Piotr Wiland

Since Specialization

Citations

This map shows the geographic impact of Piotr Wiland's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Piotr Wiland with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Piotr Wiland more than expected).

Fields of papers citing papers by Piotr Wiland

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Piotr Wiland. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Piotr Wiland. The network helps show where Piotr Wiland may publish in the future.

Co-authorship network of co-authors of Piotr Wiland

This figure shows the co-authorship network connecting the top 25 collaborators of Piotr Wiland. A scholar is included among the top collaborators of Piotr Wiland based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Piotr Wiland. Piotr Wiland is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Winiarski, Sławomir, Robert Dymarek, Marta Madej, et al.. (2024). Ebbing Strength, Fading Power: Unveiling the Impact of Persistent Fatigue on Muscle Performance in COVID-19 Survivors. Sensors. 24(4). 1250–1250.

Ciaffi, Jacopo, Suzanne C. Cannegieter, Eva M. Hoekstra, et al.. (2024). Untangling the relationship between smoking and systemic sclerosis: an analysis of the EUSTAR cohort. RMD Open. 10(2). e004101–e004101. 3 indexed citations

Felis‐Giemza, Anna, et al.. (2024). Multicenter evaluation of tofacitinib retention and safety in rheumatoid arthritis – why cardiovascular risk factors do not equate to overt risk. Reumatologia/Rheumatology. 61(6). 414–423. 1 indexed citations

Madej, Marta, et al.. (2024). The analysis of the pulmonary domain involvement in Sjögren’s disease. Therapeutic Advances in Musculoskeletal Disease. 16. 1759720X241305218–1759720X241305218.

Winiarski, Sławomir, Marta Madej, Agata Sebastian, et al.. (2023). Effect of COVID-19 on Musculoskeletal Performance in Gait and the Timed-Up and Go Test. Journal of Clinical Medicine. 12(13). 4184–4184. 8 indexed citations

Iwaszko, Milena, Jerzy Świerkot, Barbara Wysoczańska, et al.. (2021). Relationship Between Interleukin-6 −174G/C Genetic Variant and Efficacy of Methotrexate Treatment in Psoriatic Arthritis Patients. Pharmacogenomics and Personalized Medicine. Volume 14. 157–166. 6 indexed citations

Sebastian, Agata, et al.. (2021). Differences in clinical phenotypes of primary Sjögren’s syndrome depending on early or late onset. Advances in Clinical and Experimental Medicine. 30(11). 1141–1146. 2 indexed citations

Sierakowska, Matylda, Marzena Olesińska, Marek Brzosko, et al.. (2019). Factors associated with quality of life in systemic sclerosis: a cross-sectional study. Quality of Life Research. 28(12). 3347–3354. 27 indexed citations

Sebastian, Agata, et al.. (2017). The variety of clinical presentations in IgG4-related disease in Rheumatology. Rheumatology International. 38(2). 303–309. 6 indexed citations

10.

Kucharz, Eugeniusz J., Bogdan Batko, Marek Brzosko, et al.. (2017). Biopodobne leki biologiczne w reumatologii. Via Medica Journals. 2(1). 191–204. 1 indexed citations

11.

Szmyrka−Kaczmarek, Magdalena, et al.. (2014). Peripheral blood Th17/Treg imbalance in patients with low-active systemic lupus erythematosus. SHILAP Revista de lepidopterología. 1 indexed citations

12.

Olesińska, Marzena, et al.. (2014). Fertility, pregnancy planning, and pharmacotherapy during the pregnancy, postpartum and breastfeeding period in patients with rheumatoid arthritis and other inflammatory arthropathies. Reumatologia/Rheumatology. 52(1). 7–21. 1 indexed citations

13.

Nowak, Beata, et al.. (2013). Anti-ox-LDL antibodies and anti-ox-LDL-B2GPI antibodies in patients with systemic lupus erythematosus.. PubMed. 21(3). 331–5. 17 indexed citations

14.

Świerkot, Jerzy, et al.. (2012). Clinical immunology<br>Effect of methotrexate on serum levels of anti-CCP antibodies and different classes of rheumatoid factors in rheumatoid arthritis patients. Central European Journal of Immunology. 37(3). 253–257. 3 indexed citations

15.

Szmyrka−Kaczmarek, Magdalena & Piotr Wiland. (2012). Belimumab – new treatment opportunities in systemic lupus erythematosus. Reumatologia/Rheumatology. 50(4). 349–361. 1 indexed citations

16.

Tłustochowicz, Witold, et al.. (2011). „Długoterminowa ocena bezpieczeństwa i skuteczności leczenia biologicznego młodzieńczego idiopatycznego zapalenia stawów” – prezentacja polskiego rejestru elektronicznego. SHILAP Revista de lepidopterología.

17.

Żuber, Zbigniew, et al.. (2011). “Long-term assessment of safety and efficacy of biological treatment in juvenile idiopathic arthritis” – the register of Polish patients. Reumatologia/Rheumatology. 49(1). 10–15.

18.

Wiland, Piotr, et al.. (2008). The Role of Jak/STAT Signaling in Rheumatoid Arthritis. Advances in Clinical and Experimental Medicine. 17(4). 447–452. 1 indexed citations

19.

Tłustochowicz, Witold, Marek Brzosko, Anna Filipowicz‐Sosnowska, et al.. (2008). STANDARDS OF TREATMENT Position of the Expert Panel of the National Consultant for Rheumatology concerning diagnosis and treatment of rheumatoid arthritis. Reumatologia/Rheumatology. 46(3). 111–114. 1 indexed citations

20.

Wiland, Piotr, et al.. (2007). Review paper The role of abatacept in the treatment of rheumatoid arthritis. Reumatologia/Rheumatology. 45(4). 205–214.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact